Shilpa Medicare Limited received final approval for OERIS™ marketing authorization and plans a product launch across India.
1 report, 1 independent
Updated Sep 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Shilpa Medicare Limited received final approval for OERIS™ marketing authorization and plans a product launch across India.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Central Drugs Standard Control Organization
Apex Drug Regulatory Body
Nothing else this week.